Localized upper extremity edema secondary to Bruton's tyrosine kinase inhibition

被引：0

作者：

Leung, Bonnie W. ^{[1
,2
,3
]}

Fay, Christopher J. ^{[1
,3
]}

Said, Jordan T. ^{[1
,4
]}

Sheets, Anthony R. ^{[5
]}

Lian, Christine G. ^{[5
]}

Brown, Jennifer R. ^{[3
,4
]}

Castillo, Jorge J. ^{[3
,4
]}

Sarosiek, Shayna ^{[3
]}

Flynn, Catherine ^{[3
]}

Leboeuf, Nicole R. ^{[1
,3
,4
,6
]}

机构：

[1] Brigham & Womens Hosp, Dept Dermatol, Boston, MA USA

[2] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA USA

[3] Dana Farber Canc Inst, Boston, MA USA

[4] Harvard Med Sch, Boston, MA USA

[5] Brigham & Womens Hosp, Dept Pathol, Boston, MA USA

[6] DFCI, Ctr Cutaneous Oncol, 375 Longwood Ave, Boston, MA 02115 USA

来源：

LEUKEMIA & LYMPHOMA | 2023年 / 64卷 / 12期

关键词：

EFFICACY;

D O I：

10.1080/10428194.2023.2245091

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2047 / 2050

页数：4

共 17 条

[1] Bruton's tyrosine kinase inhibitors for the treatment of rheumatoid arthritis
Whang, Jennifer A.
Chang, Betty Y.
DRUG DISCOVERY TODAY, 2014, 19 (08) : 1200 - 1204
[2] Investigational Bruton's tyrosine kinase inhibitors for the treatment of rheumatoid arthritis
Norman, Peter
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (08) : 891 - 899
[3] Bruton's tyrosine kinase as a promising therapeutic target for multiple sclerosis
Saberi, Darius
Geladaris, Anastasia
Dybowski, Sarah
Weber, Martin S.
EXPERT OPINION ON THERAPEUTIC TARGETS, 2023, 27 (4-5) : 347 - 359
[4] The role of Bruton's tyrosine kinase inhibitors in the management of mantle cell lymphoma
Hanna, Kirollos S.
Campbell, Maren
Husak, Alex
Sturm, Sabrina
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (05) : 1190 - 1199
[5] Bruton's Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE?
Lorenzo-Vizcaya, Ana
Fasano, Serena
Isenberg, David A.
IMMUNOTARGETS AND THERAPY, 2020, 9 : 105 - 110
[6] Non-Covalent Bruton's Tyrosine Kinase Inhibitors in the Treatment of Chronic Lymphocytic Leukemia
Montoya, Skye
Thompson, Meghan C. C.
CANCERS, 2023, 15 (14)
[7] Bruton's tyrosine kinase-bearing B cells and microglia in neuromyelitis optica spectrum disorder
Liu, Ye
Huang, Zhenning
Zhang, Tian-Xiang
Han, Bin
Yang, Guili
Jia, Dongmei
Yang, Li
Liu, Qiang
Lau, Alexander Y. L.
Paul, Friedemann
Verkhratsky, Alexei
Shi, Fu-Dong
Zhang, Chao
JOURNAL OF NEUROINFLAMMATION, 2023, 20 (01)
[8] HM71224, a selective Bruton's tyrosine kinase inhibitor, attenuates the development of murine lupus
Kim, Yu-Yon
Park, Ki Tae
Jang, Sun Young
Lee, Kyu Hang
Byun, Joo-Yun
Suh, Kwee Hyun
Lee, Young-Mi
Kim, Young Hoon
Hwang, Kwang Woo
ARTHRITIS RESEARCH & THERAPY, 2017, 19
[9] Treatment of Patients with Relapsed or Refractory Mantle-Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase
Song, Yuqin
Zhou, Keshu
Zou, Dehui
Zhou, Jianfeng
Hu, Jianda
Yang, Haiyan
Zhang, Huilai
Ji, Jie
Xu, Wei
Jin, Jie
Lv, Fangfang
Feng, Ru
Gao, Sujun
Guo, Haiyi
Zhou, Lei
Elstrom, Rebecca
Huang, Jane
Novotny, William
Wei, Rachel
Zhu, Jun
CLINICAL CANCER RESEARCH, 2020, 26 (16) : 4216 - 4224
[10] What management in relapsed patients after inhibitors of Bruton's tyrosine kinase and B-cell lymphoma 2?
Tournilhac, Olivier
HEMATOLOGIE, 2020, 26 : 34 - 48

← 1 2 →